Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.
At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.
As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.
To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.
ESSENTIAL JOB FUNCTIONS:
The Associate Director, Medical & Regulatory Writing serves as a subject matter expert in the writing and production of clinical documents such as the writing of clinical protocols, protocol amendments, clinical study reports, Investigator’s Brochures, and briefing books. This role is also accountable for Clinical Trial Transparency & Disclosure (CTD) responsibilities and oversight of vendors carrying out such work. The position requires the ability to work collaboratively with cross-functional teams in a fast-paced environment. The qualified candidate will also have experience in oversight of external vendors. There needs to be a very strong understanding of document timelines as planning is critical.
Serves as the assigned medical writer and subject matter expert in preparing clinical regulatory documents through all phases of clinical research.
Execute clinical trials transparency and disclosures (CTD) book of work and provide vendor oversight
Collaborates with the cross-functional team comprised of regulatory affairs, clinical development, clinical operations, biostatistics, pharmacology, translational research, manufacturing, etc. to interpret study results and ensure study results and statistical interpretations are accurately and clearly reflected in relevant documents.
Manages the document review process ensuring conflicting and/or ambiguous comments are clarified and appropriately addressed.
Works closely with the study team to reach consensus on timelines for deliverables.
Completes documents according to agreed-upon timelines for deliverables and follows up with the study team as needed to meet timeline commitments.
Adhere to established regulatory standards, including ICH-E3 guidelines and company SOPs.
Support the development, improvement and maintenance of regulatory and scientific writing work practice documents, SOPs, and document templates to ensure consistency and efficiency.
Represent medical writing in cross-functional team meetings.
Collaborate with department heads and staff members of cross-functional groups, including clinical development, clinical operations, data management, biostatistics, regulatory affairs, and medical affairs as necessary to deliver documents with high quality on time.
Adhere to established regulatory standards, including ICH-E3 guidelines and company SOPs.
Support the development, improvement and maintenance of medical writing work practice documents, SOPs, and document templates to ensure consistency and efficiency.
Lead the development of overall global clinical trials transparency and disclosures policy with key stakeholders, updating the policy as necessary
Lead teams in the preparation and maintenance of CCI and PPD rules across programs, ensuring consistency of publicly disclosed information across countries, websites, databases, and documents
Ensure lean writing practices for regulatory documents such as Clinical Trial Protocols, Investigator's Brochures, Informed Consent templates and Clinical Study Reports to minimize CCI and PPD
Analyze, validate, and prioritize complex and dynamic information from a diverse range of sources in response to technical and operational challenges
Manage, track and present assigned book-of-work, compile and report performance metrics
Manage the preparation of plain language (layperson) synopses and summaries and redaction of clinical documents in accordance with FDA requirements, EMA Policy 0070, EU Clinical Trial Regulation, Health Canada Public Release of Clinical Information (PRCI), and other global regulations
Educate and provide company-wide awareness of transparency/disclosure regulations and industry trends, as well as requirements for layperson summaries and clinical study diversity planning.
Coordinate efforts of cross-functional teams to produce documents & postings (e.g., plain language (layperson) summaries, interim and/or results postings, and redaction documents), acting as liaison between the vendor and internal teams
For relevant trials, collaborate with internal and external stakeholders to develop and implement diversity action plans in accordance with FDA guidance
Work on multiple projects/across programs, coordinating work plans that align with corporate timelines and strategic plans
Oversight of vendors in the Clinical trial transparency and disclosure space
Must have proficiency in the use of Veeva or equivalent It software for document creation, review, and QC including applications for citation of literature references and creation of list of references in Word documents.
Maintain current knowledge of industry trends and best practices for medical writing.
Performs other duties as assigned
JOB SPECIFICATIONS:
Masters or advanced degree in scientific, medical, or clinical discipline (eg, PhD, PharmD, or equivalent) is required. PhD degree is preferred.
Must have a minimum of 8-10 years of relevant industry experience as a regulatory/scientific writer in a pharmaceutical, biotech, or CRO environment. Must have CTD experience, vendor oversight a plus. Oncology experience preferred.
Must have experience authoring clinical study reports, protocols, protocol amendments, Investigator’s Brochures. Experience authoring briefing books and Module 2 clinical summaries (2.5, 2.7.3, 2.7.4) is a plus.
Ability to work effectively in a collaborative team environment where results are achieved through influence, cooperation, and the incorporation of multiple points of view.
Solid understanding of drug development, clinical research, data analysis, Common Technical Document (CTD), ICH guidelines, GxP, regulatory interactions, and relevant regulations, requirements and guidance associated with document preparation and submission.
Ability to manage competing priorities in a fast-paced environment.
Excellent problem solving, organizational, and analytical critical thinking skills.
Excellent written and verbal communication skills.
Strong attention to detail related to consistency, grammar, syntax, and formatting.
Familiarity with eCTD-compliant templates and with the use of document formatting tools such as ISI writer, Liquent Smart Desk, Acumen Stylus, or other formatting tools is a plus.
Proficient in MS Office Suite, EndNote, and Adobe Acrobat.
Experience with use of an EDMS such as Documentum, Core Dossier, or Veeva.
Ability to travel up to approximately 10% of the time.
Makes decisions for assigned programs or functional areas, balancing priorities and resolving routine challenges; escalates high-impact or cross-functional decisions as needed.
Facilitates cross-functional coordination for assigned programs or initiatives, ensuring alignment and timely execution of deliverables.
The base range for an Associate Director is $184,000 - $211,000. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
Kura’s Values that are used for candidate selection and performance assessments:
We work as one for patients
We are goal-focused and deliver with excellence
We are science-driven courageous innovators
We strive to bring out the best in each other and ourselves
The Kura Package
Career advancement/ development opportunities
Competitive comp package
Bonus
401K + Employer contributions
Generous stock options
ESPP Plan
20 days of PTO to start
18 Holidays (Including Summer & Winter Break)
Generous Benefits Package with a variety of plans available with a substantial employer match
Paid Paternity/Maternity Leave
In-Office Catered lunches
Home Office Setup
Lifestyle Spending Stipend
Commuter Stipend (Boston Office)
Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives.
Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit.
Kura developed and is commercializing KOMZIFTI® (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.
Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
If you are a California resident, please see the attached Privacy Notice CA Privacy Notice